TACR1 and central nervous system cancer: Therefore, NK-1R antagonist drugs can be considered as a new magic bullet in the treatment of glioma, perhaps more accurately called a “intelligent bullet”, and we suggest the use of aprepitant to treat DIPG in combination with radiotherapy.